Drug Shortage Report for JAMP ATORVASTATIN CALCIUM

Last updated on 2023-03-11 History
Report ID 183651
Drug Identification Number 02504219
Brand name JAMP ATORVASTATIN CALCIUM
Common or Proper name Atorvastatin calcium
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) ATORVASTATIN
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 3x10
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-02-06
Estimated end date 2023-03-10
Actual end date 2023-03-07
Shortage status Resolved
Updated date 2023-03-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-02-06 English Compare
v2 2023-02-06 English Compare
v3 2023-02-06 French Compare
v4 2023-02-07 English Compare
v5 2023-02-09 English Compare
v6 2023-02-09 French Compare
v7 2023-03-11 English Compare
v8 2023-03-11 French Compare

Showing 1 to 8 of 8